Thu. 7 Mar 2024, 4:02pm ET
Benzinga
Earnings, Earnings Beats, News
Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.030) per share which beat the analyst consensus estimate of $(0.040) by 25 percent. The company reported quarterly sales of $2.100 million which beat the analyst consensus estimate of $1.310 million by 60.35 percent. This is a 10.53 percent increase over sales of $1.900 million the same period last year.